JP2005519073A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519073A5
JP2005519073A5 JP2003567333A JP2003567333A JP2005519073A5 JP 2005519073 A5 JP2005519073 A5 JP 2005519073A5 JP 2003567333 A JP2003567333 A JP 2003567333A JP 2003567333 A JP2003567333 A JP 2003567333A JP 2005519073 A5 JP2005519073 A5 JP 2005519073A5
Authority
JP
Japan
Prior art keywords
compound according
compound
group
metabolite
sleep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003567333A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519073A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/001845 external-priority patent/WO2003068148A2/en
Publication of JP2005519073A publication Critical patent/JP2005519073A/ja
Publication of JP2005519073A5 publication Critical patent/JP2005519073A5/ja
Withdrawn legal-status Critical Current

Links

JP2003567333A 2002-01-18 2003-01-21 睡眠標的モジュレーターを使用する睡眠障害の治療 Withdrawn JP2005519073A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34991202P 2002-01-18 2002-01-18
US35732002P 2002-02-15 2002-02-15
PCT/US2003/001845 WO2003068148A2 (en) 2002-01-18 2003-01-21 Treatment of sleep disorders using sleep target modulators

Publications (2)

Publication Number Publication Date
JP2005519073A JP2005519073A (ja) 2005-06-30
JP2005519073A5 true JP2005519073A5 (https=) 2005-12-22

Family

ID=27737408

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003567333A Withdrawn JP2005519073A (ja) 2002-01-18 2003-01-21 睡眠標的モジュレーターを使用する睡眠障害の治療

Country Status (6)

Country Link
US (2) US20030232839A1 (https=)
EP (1) EP1471913A2 (https=)
JP (1) JP2005519073A (https=)
AU (1) AU2003210598A1 (https=)
CA (1) CA2473586A1 (https=)
WO (1) WO2003068148A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY28538A1 (es) * 2003-09-26 2005-04-29 Vertex Pharma Derivados de fenil-piperazina como moduladores de receptores muscarínicos
WO2005107700A2 (en) * 2004-04-26 2005-11-17 Immuneregen Biosciences, Inc. Anti-aging effects of substance p
JP4613031B2 (ja) * 2004-05-06 2011-01-12 エスエス製薬株式会社 催眠剤組成物
DK1940467T3 (da) * 2005-09-09 2017-02-13 Paladin Labs Inc Lægemiddelsammensætning med langvarig frigivelse
CN101252932B (zh) * 2005-09-09 2012-10-03 安吉利尼莱博法姆有限责任公司 用于一天给药一次的曲唑酮组合物
CA2641821C (en) 2006-02-16 2017-10-10 Imthera Medical, Inc. An rfid-based apparatus, system, and method for therapeutic treatment of a patient
US20110077200A1 (en) * 2006-12-06 2011-03-31 Somaxon Pharmaceuticals, Inc. Combination therapy using low-dose doxepin for the improvement of sleep
CA2697826A1 (en) 2007-10-09 2009-04-16 Imthera Medical, Inc. System and method for neural stimulation
EP2349139B1 (en) 2008-10-09 2017-05-31 Imthera Medical, Inc. Stimulation of a hypoglossal nerve for controlling the position of a patient's tongue
ES2370147T5 (es) † 2009-10-23 2019-03-06 Gruppo Cimbali Spa Máquina de café con regulación de presión de distribución y procedimiento relacionado con la misma
KR20120101650A (ko) 2009-11-10 2012-09-14 임테라 메디칼, 인코포레이티드 환자 혀의 위치를 제어하기 위한 혀밑 신경 자극용 시스템
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8691275B2 (en) 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
AU2012214553B2 (en) 2011-02-11 2015-07-09 Sociétés des Produits Nestlé S.A. Multiparticulate L-menthol formulations and related methods
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
US20120315337A1 (en) * 2011-06-07 2012-12-13 Shah Syed Multiparticulate 5-htp compositions and related methods
WO2013074390A1 (en) * 2011-11-14 2013-05-23 Merck Sharp & Dohme Corp. Triazolopyridinone pde10 inhibitors
ES2706152T3 (es) 2013-04-23 2019-03-27 Zx Pharma Llc Composición entérica de múltiples partículas revestida con subrevestimiento proteico
US10420756B2 (en) 2015-03-26 2019-09-24 Sen-Jam Pharmaceutical Llc. Methods and compositions to inhibit symptoms associated with veisalgia
JP7345495B2 (ja) * 2018-04-06 2023-09-15 ビーエーエスエフ ソシエタス・ヨーロピア アミンを合成する方法
EP4615585A1 (en) * 2022-11-11 2025-09-17 Gilgamesh Pharmaceuticals, Inc. Methods of using trazodone to reverse the effects of 5-ht2a receptor agonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders

Similar Documents

Publication Publication Date Title
JP2005519073A5 (https=)
NZ788543A (en) Dimethyltryptamine derivatives and their use in psychedelic-assisted psychotherapy
JP2011515482A5 (https=)
JP2014051526A5 (https=)
JP2009143956A5 (https=)
JP2014507455A5 (https=)
JP2018135343A5 (https=)
JP2011519854A5 (https=)
JP2009531277A5 (https=)
JP2014508811A5 (https=)
JP2010504343A5 (https=)
JP2007508361A5 (https=)
ME02766B (me) Derivati arilmetoksi izoindolina i kompozicije koje ih obuhvataju i postupci njihove primene
JP2010503688A5 (https=)
JP2005508349A5 (https=)
JP2004525117A5 (https=)
ME01421B (me) 5-supstituisani derivati kinazolinona kao protivtumorska sredstva
JP2014506907A5 (https=)
JP2007523155A5 (https=)
JP2013537203A5 (https=)
JP2007508360A5 (https=)
JP2019519587A5 (https=)
JP2013544860A5 (https=)
JP2015517555A5 (https=)
JP2005539045A5 (https=)